Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. CAPR

Market Cap: $481.36M

CI

Capricor Therapeutics, Inc.

CAPR
NASDAQUSD
Purchase CAPR
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Linda Marbán

Co-Founder, President, Chief Executive Officer & Director

Compensation
$580,645
Frank Isaac Litvack FACC

Executive Chairman of the Board

Compensation
$120,000
Anthony J. Bergmann

Chief Financial Officer & Corporate Treasurer

Compensation
$584,750
Karen G. Krasney

Executive Vice President, General Counsel & Secretary

Compensation
$500,718
Minghao Sun

Senior Vice President of Quality Control, Research & Product Development

Compensation
Compensation not disclosed
Nathaniel Hogan

Director of Biostatistics of Capricor Therapeutics

Compensation
Compensation not disclosed
Catherine Lee Kelleher

Consultant

Compensation
Compensation not disclosed
Kristi A. H. Elliott

Chief Operating & Science Officer

Compensation
Compensation not disclosed
Mark Awadalla

Chief Development Officer

Compensation
Compensation not disclosed
Michael Maurer

Chief Commercial Officer

Compensation
Compensation not disclosed
Micheal Binks

Chief Medical Officer

Compensation
Compensation not disclosed